CompletedNot Applicable

Otogenic CSVT Retrospective Case Series and Associated Thrombophilia

Israel9 participantsStarted 2018-12-02

Plain-language summary

The aim of this study is to report the clinical presentation, Microbiological, laboratory and imaging evaluation, prothrombotic factors analysis, medical and surgical management and outcomes in children with Otogenic Cerebral Sinus Vein Thrombosis (CSVT).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age of 18 years or younger * both sexes are included * a clinical or radiological finding of mastoiditis in the patient's file * Documentation of CSVT in an imaging study, either CT or MRI. Patient's exclusion criteria * age above 18 years * lack of a clinical or radiological finding of mastoiditis in the patient's file * Lack of documentation of CSVT in an imaging study, either CT or MRI. * previous unprovoked venous thromboembolism event.

What they're measuring

Clinical Presentation

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Cultures result

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Morbidity and Mortality

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Surgical intervention

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Thrombophilia evaluation tests

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Trial details

NCT IDNCT03864055

SponsorHaEmek Medical Center, Israel

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-02-03

View on ClinicalTrials.gov More Lateral Sinus Thrombosis trials

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Clinical Presentation

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Cultures result

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Morbidity and Mortality

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Surgical intervention

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee

Thrombophilia evaluation tests

Timeframe: All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee